Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				18 to 85				Other				GLU_07 NCT00772824


2.		Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Other				0309006308 NCT00195013


3.		Efficacy of an Oral Formula in Prevention of Anti-Cancer Therapy Side Effects

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				Over 18				Other				06.23.CLI NCT00455247


4.		Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 and over				Other				GI-05-0024 NCT00255229

Last Modified: 6/14/2008 First Published: 8/13/2006


5.		Phase II Randomized Pilot Study of Glutamine for Vincristine-Induced Neuropathy in Pediatric Patients With Lymphoma, Leukemia, or Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				5 to 21				Other				CPMC-AAAA6806 CPMC-ICCR-3349, NCT00365768


6.		Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				18 and over				Other				EC1432-00 HARECCTR0500034, NCT00563498

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute